Health Agencies Set Stage for U.S. to Import Cheaper Drugs
- Two-pronged plan is latest attempt to pare prescription costs
- Buying from abroad has bipartisan backing; drugmakers opposed
Photographer: Joe Raedle/Getty Images
This article is for subscribers only.
The Trump administration cracked open the door for the eventual importation of cheaper medicines from abroad, the latest salvo in a battle to bring down drug costs.
The U.S. Department of Health and Human Services and the Food and Drug Administration on Wednesday published what they dubbed a “safe importation action plan” that could allow for certain medications originally intended for foreign markets to be sold to U.S. consumers.